Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2
Sign Up to like & getrecommendations! Published in 2019 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfy132
Abstract: Abstract Background A reduction in renal angiomyolipoma volume observed with everolimus (EVE) treatment in patients with tuberous sclerosis complex (TSC) has been postulated to translate to clinical benefit by reducing the risk of renal hemorrhage… read more here.
Keywords: patients tuberous; tuberous sclerosis; exist exist; sclerosis complex ... See more keywords
Monitoring and Managing Patients with Tuberous Sclerosis Complex: Current State of Knowledge
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Multidisciplinary Healthcare"
DOI: 10.2147/jmdh.s266990
Abstract: Abstract Tuberous sclerosis complex (TSC) is a rare genetic disease of autosomal dominant transmission that, in most cases, results from the presence of pathogenic variants of the TSC1 or TSC2 genes, encoding hamartin and tuberin,… read more here.
Keywords: managing patients; patients tuberous; monitoring managing; tuberous sclerosis ... See more keywords